Everyone’s favorite drug-price punching bag, Martin Shkreli, is back in the news. This time he’s trying to rescue the struggling biotech startup KaloBios.
from Forbes – Tech http://ift.tt/1Hb5XTQ
via IFTTT
Everyone’s favorite drug-price punching bag, Martin Shkreli, is back in the news. This time he’s trying to rescue the struggling biotech startup KaloBios.
from Forbes – Tech http://ift.tt/1Hb5XTQ
via IFTTT